New Mpox Strain Detected in UK Traveler

New Mpox Strain Detected in UK Traveler

A concerning development has emerged in the United Kingdom with the identification of a novel mpox virus strain. Health officials in England have confirmed the detection of a recombinant mpox virus in an individual who had recently traveled from Asia. This newly identified strain is a hybrid, blending elements of clade II and clade I of the virus. Notably, clade I is known to be associated with more severe illness.

The UK Health Security Agency (UKHSA) has stated that this development was not entirely unforeseen, given the ongoing circulation of both clades. However, it underscores the dynamic nature of the mpox virus and the critical need for continuous genomic surveillance to track its evolution. This news follows earlier reports of locally acquired mpox cases in various countries, including the United States, Spain, Italy, the Netherlands, and Portugal, which the agency was already monitoring. Locally acquired cases, meaning those contracted by individuals who haven't recently traveled to regions where the virus is endemic, are a particular focus, especially in areas where they are less common.

Understanding Mpox

Mpox, previously known as monkeypox, is an infectious disease caused by the monkeypox virus. According to the World Health Organization (WHO), typical symptoms include a painful rash, swollen lymph nodes, fever, headache, muscle aches, back pain, and a general feeling of exhaustion.

The virus's name stems from its initial discovery in monkeys. It belongs to the same viral family as smallpox and can spread through direct physical contact, as outlined by the Centers for Disease Control and Prevention (CDC).

There are two primary groupings, or clades, of the mpox virus: clade I and clade II, each with further subdivisions. Clade II is generally linked to milder to moderate illness, whereas clade I has the potential to cause more severe outcomes. Clade II has been present in the United States since 2022, with a significant number of infections reported. While clade I has been identified in individuals traveling internationally to the U.S., recent cases in California mark the first instances of local spread of this more severe clade within the country. Clade I has also been a factor in recent outbreaks in Africa.

How Mpox Spreads

Transmission of both mpox clades can occur through close contact with an infected individual, contact with contaminated materials, or exposure to infected live or deceased wild animals. The risk from animals is particularly elevated in regions of Western and Central Africa, where the virus is more prevalent.

Infections are frequently associated with intimate or sexual contact. The most common pathways for human-to-human transmission involve direct contact with mpox lesions or scabs, as well as exposure to infected bodily fluids such as mucus, saliva, or blood. There is also a risk of mother-to-child transmission during pregnancy or around the time of birth.

Animals can transmit the virus to humans through bites and scratches. Additionally, humans can contract the virus by coming into contact with infected animal bodily fluids while engaged in activities like hunting, preparing, cooking, or consuming animals, according to the WHO. The virus can also persist on objects, fabrics, and surfaces that have not been properly disinfected. It's important to note that casual transmission via respiratory exposure, such as sharing the same air in a room, is considered to be of low likelihood.

Mpox Symptoms to Watch For

Symptoms of mpox typically appear within 21 days of exposure, with an average incubation period of three to 17 days before symptoms manifest, according to both the CDC and WHO.

A characteristic symptom is a rash that develops in distinct stages and can appear on the hands, feet, chest, face, mouth, or genital areas. This rash may initially resemble raised dots or pimples. Symptoms generally resolve within two to four weeks.

While most individuals recover without the need for significant medical intervention, severe illness is a possibility.

Other common mpox symptoms include:

  • Fever
  • Chills
  • Swollen lymph nodes
  • Extreme fatigue
  • Muscle and back aches
  • Headache
  • Respiratory symptoms, such as a sore throat, nasal congestion, or cough

If you believe you may have been exposed to mpox and begin to experience any of these symptoms, it is recommended to consult a doctor. They may advise on testing and supportive care. If you suspect you are infected, it is crucial to limit close contact with others and wear a mask in public settings.

Related articles